Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 10, 2008 6:47:19 PM CDT


Stories related to: Effexor

Stories

2 Stories

  • February 2008
    • Feds OK Wyeth's New Antidepressant

      Feds OK Wyeth's New Antidepressant

      (Newser) - Antidepressant Effexor XR will soon lose patent protection, and maker Wyeth is hoping Pristiq, the successor drug approved today by the FDA, will soften the financial blow. Higher-ups at the company gush over Pristiq's advantages, including zero acclimation time and no liver interaction, and hope that sales will offset losses to generic versions of Effexor, the New York Times reports. More »

      Tags

      stock market   FDA   antidepressant   Wyeth   metabolism   Effexor   patent expiration

  • January 2008

2 Stories

Today's Most Popular

Loading...

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »